• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4595849)   Today's Articles (2475)   Subscriber (49336)
Number Citation Analysis
26
Barkas F, Liberopoulos E, Ntekouan SF, Milionis H. Sodium-glucose transport protein 2 inhibitors and risk of incident stroke: A systematic review and meta-analysis. Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
27
Rizos C, Liamis G, Skoumas I, Rallidis L, Tziomalos K, Skalides E, Kotsis V, Garoufi A, Athyros V, Kolovou G, Sfikas G, Bilianou E, Koutagiar I, Kiouri E, Agapakis D, Zacharis E, Antza C, Attilakos A, Katsiki N, Anagnostis P, Koumaras C, Liberopoulos E. Clinical characteristics of patients with familial hypercholesterolemia: Data from the HELLAS-FH registry. Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
28
Rizos C, Liamis G, Skoumas I, Rallidis L, Tziomalos K, Skalides E, Kotsis V, Garoufi A, Athyros V, Kolovou G, Sfikas G, Bilianou E, Koutagiar I, Kiouri E, Agapakis D, Zacharis E, Antza C, Attilakos A, Katsiki N, Koumaras C, Liberopoulos E. Cholesterol levels of high-density lipoprotein (HDL-C), APOB/APOA1 ratio and cardiovascular risk in patients with familial hypercholesterolemia (FH): Data from the HELLAS-FH registry. Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
29
Rizos C, Skoumas I, Rallidis L, Tziomalos K, Skalides E, Kotsis V, Garoufi A, Athyros V, Kolovou G, Sfikas G, Bilianou E, Koutagiar I, Kiouri E, Agapakis D, Zacharis E, Antza C, Attilakos A, Katsiki N, Anagnostis P, Elisaf M, Liberopoulos E. Latest European guidelines for dyslipidemias in the setting of familial hypercholesterolemia: Data from the hellas-fh registry. Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
30
Rallidis L, Vlachopoulos C, Liberopoulos E, Skoumas I, Kiouri E, Koutagiar I, Anastasiou G, Kosmas N, Tousoulis D, Iliodromitis E. The new LDL-C target <55 mg/dL is achieved by less than 40% of very high risk patients with familial hypercholesterolaemia despite receiving PCSK9 inhibitors: real world data. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
31
Liberopoulos E, Rizos C, Garoufi A, Kolovou G, Athyros V, Skoumas I, Kotsis V, Rallidis L, Tziomalos K, Skalides E, Attilakos A, Katsiki N, Koutagiar I, Antza C, Elisaf M. P5324Children with familial hypercholesterolemia: lipid profile, treatment and evaluation of different formulas for calculating low-density lipoprotein cholesterol: an analysis from the HELLAS-FH registry. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
32
Liberopoulos E, Rizos C, Skoumas I, Tziomalos K, Rallidis L, Kotsis V, Athyros V, Skalides E, Kolovou G, Garoufi A, Koutagiar I, Papagianni M, Kiouri E, Antza C, Elisaf M. P5321The association of Lp(a) levels and cardiovascular disease in adult patients with familial hypercholesterolemia: analysis from the HELLAS-FH registry. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
33
Fountas E, Diakoumakou O, Kolovou V, Stratakis S, Zacharis E, Liberopoulos E, Matsouka F, Tsoutsinos A, Mastorakou I, Katsikas T, Mavrogeni S, Hatzigeorgiou G, Kolovou G. P5365Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolemia phenotype. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0330] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
34
Barkas F, Elisaf M, Dimitriou T, Liamis G, Rizos E, Liberopoulos E. Distance To Targets Of Low-Density Lipoprotein Cholesterol And Eligibility For Treatment With Pcsk9 Inhibitors In Patients At High Cardiovascular Risk. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
35
Rizos C, Garoufi A, Elisaf M, Kolovou G, Athyros V, Skoumas I, Kotsis V, Rallidis L, Tziomalos K, Skalides E, Attilakos A, Katsiki N, Koutagiar I, Antza C, Kiouri E, Papagianni M, Loulakakis M, Liberopoulos E. Children With Familial Hypercholesterolemia: Cardiometabolic Profile Data From The Hellas-Fh Registry. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
36
Rizos C, Elisaf M, Skoumas I, Tziomalos K, Rallidis L, Kotsis V, Athyros V, Skalides E, Kolovou G, Garoufi A, Koutagiar I, Papagianni M, Kiouri E, Antza C, Katsiki N, Zacharis E, Attilakos A, Liberopoulos E. Cardiovascular Disease And Lp(A) Levels In Adult Patients With Familial Hydrocholesterolemia. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
37
Rizos C, Elisaf M, Skoumas I, Tziomalos K, Rallidis L, Kotsis V, Athyros V, Skalides E, Kolovou G, Garoufi A, Florentin M, Koutagiar I, Papagianni M, Kiouri E, Antza C, Katsiki N, Zacharis E, Attilakos A, Liberopoulos E. Adults With Familial Hydrocholesterolemia: Latest Update On Cardiometabolic Profile From The Hellas-Fh Registry. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.639] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
38
Barkas F, Elisaf M, Filippatos T, Ntekouan SF, Sakkas N, Liberopoulos E. Lipid And Glycemic Profile Of Overweight And Obese Patients. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
39
Barkas F, Elisaf M, Liberopoulos E, Klouras E, Kei A, Liontos A, Megapanou E, Lamouri C, Rizos E. Non-alcoholic fatty liver disease and its association with incident diabetes in statin-treated individuals. Atherosclerosis 2018. [DOI: 10.1016/j.atherosclerosis.2018.06.603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
40
Rizos C, Barkas F, Athyros V, Antza C, Attilakos A, Elisaf M, Zacharis E, Rallidis L, Kiouri E, Kolovou G, Loulakakis M, Boufidou A, Skoumas I, Liberopoulos E. Carbohydrate metabolism in patients with familial hypercholesterolemia: Data from the HELLAS-FH registry. Atherosclerosis 2018. [DOI: 10.1016/j.atherosclerosis.2018.06.533] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
41
Barkas F, Filippas-Ntekouan S, Liberopoulos E, Christopoulou E, Pantazi A, Tzavella E, Elisaf M, Liamis G. Clinical application of PCSK9 inhibitors in a specialized lipid clinic. Atherosclerosis 2018. [DOI: 10.1016/j.atherosclerosis.2018.06.751] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
42
Angouridis A, Georgoula M, Tellis C, Filippatos T, Tselepis A, Liberopoulos E, Elisaf M. Serum PCSK9 levels are increased in obese subjects and negatively correlated with a mediterranean diet score. Atherosclerosis 2018. [DOI: 10.1016/j.atherosclerosis.2018.06.800] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
43
Barkas F, Pappa E, Liberopoulos E, Filippatos T, Florentin M, Christopoulou F, Elisaf M, Liamis G. Lipid target attainment in a specialized lipid clinic. Atherosclerosis 2018. [DOI: 10.1016/j.atherosclerosis.2018.06.251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
44
Rizos C, Athyros V, Antza C, Attilakos A, Elisaf M, Zacharis E, Rallidis L, Katsiki N, KiourI E, Kolovou G, Loulakakis M, Boufidou A, Skoumas I, Florentin M, Liberopoulos E. The achievement of the low-density lipoprotein cholesterol target in subjects with familial hypercholesterolemia: The role of PCSK9 inhibitors. Atherosclerosis 2018. [DOI: 10.1016/j.atherosclerosis.2018.06.534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
45
Barkas F, Elisaf M, Liberopoulos E, Rizos C, Dimitriou T, Sferopoulos D, Rizos E. Atherogenic dyslipidemia increased the risk of incident diabetes in statin-treated individuals. Atherosclerosis 2018. [DOI: 10.1016/j.atherosclerosis.2018.06.602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
46
Barkas F, Klouras E, Dimitriou T, Liamis G, Elisaf M, Liberopoulos E. Incidence of cardiovascular disease among individuals with and without familial hypercholesterolemia attending a lipid clinic. Atherosclerosis 2016. [DOI: 10.1016/j.atherosclerosis.2016.07.376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
47
Barkas F, Klouras E, Dimitriou T, Liamis G, Liberopoulos E, Elisaf M. Lipid-lowering therapy and target attainment among hypelipidemic individuals with or without familial hypercholesterolemia: Evidence from a lipid clinic. Atherosclerosis 2016. [DOI: 10.1016/j.atherosclerosis.2016.07.375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
48
Barkas F, Klouras E, Dimitriou T, Elisaf M, Liberopoulos E. Statin escape phenomenon: Does it really exist? Evidence from a lipid clinic. Atherosclerosis 2016. [DOI: 10.1016/j.atherosclerosis.2016.07.411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
49
Barkas F, Elisaf M, Rizos CV, Klouras E, Kostapanos MS, Liberopoulos E. Proton pump inhibitors and statins: a possible interaction that favors low-density lipoprotein cholesterol reduction? Hippokratia 2015;19:332-337. [PMID: 27688698 PMCID: PMC5033144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
50
Barkas F, Liberopoulos E, Kostapanos M, Rizos C, Klouras E, Elisaf M. Proton pump inhibitors and statins: a combination that favors ldl-c reduction? Atherosclerosis 2015. [DOI: 10.1016/j.atherosclerosis.2015.04.973] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
PrevPage 2 of 4 1234Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA